Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds...
Leadership
Garry A. Neil M.D.
President, CEO & Director
Mittie Doyle FACR, M.D.
Chief Medical Officer
Taylor Boyd
Chief Business Officer
Solomon H. Snyder M.D.Founder
Founder and Chairman of Scientific Advisory Board
Barbara S. Slusher Ph.D.Founder
Founder and Member of Scientific Advisory Board
Christopher Ryan Sullivan CPA
CFO & Head of Investor relations
Paul C. Varki J.D., M.P.H
Chief Legal Officer
Ashley Ivanowicz
Senior Vice President of Human Resources
Dino C. Miano Ph.D.
Senior Vice President of CMC & Technical Operations
